![Xue Bin Liu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Storia della carriera di Xue Bin Liu
Precedenti posizioni note di Xue Bin Liu
Società | Posizione | Inizio | Fine |
---|---|---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Direttore/Membro del Consiglio | 26/11/2019 | 27/07/2022 |
Fondatore | 26/11/2019 | 27/07/2022 |
Statistiche
Distribuzione geografica
Cina | 2 |
Posizioni
Director/Board Member | 1 |
Founder | 1 |
Settori
Health Technology | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 1 |
---|---|
MingMed Biotechnology Co., Ltd.
![]() MingMed Biotechnology Co., Ltd. BiotechnologyHealth Technology MingMed Biotechnology Co., Ltd. engages in the self-discovery and development of innovative drugs. Its core product QA102 is a small molecule drug candidate for the treatment of dry age-related macular degeneration. The company was founded by Guo Ming Huang, Yan Zhang, Xue Bin Liao, Hui Ou Yang, Lai Wei, Miao Liu and Ming Jin on November 26, 2019 and is headquartered in Guangzhou, China. | Health Technology |
- Borsa valori
- Insiders
- Xue Bin Liu
- Esperienza